These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2227570

  • 1. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
    Tholander B, Taube A, Lindgren A, Sjöberg O, Stendahl U, Tamsen L.
    Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B, Taube A, Lindgren A, Sjöberg O, Stendahl U, Kiviranta A, Hallman K, Holm L, Weiner E, Tamsen L.
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [Abstract] [Full Text] [Related]

  • 3. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T, Björk GR, Damber L, Holm SE, Jacobsson L, Jeppsson A, Stigbrand T, Westman G.
    Acta Radiol Oncol; 1983 Oct; 22(3):209-14. PubMed ID: 6312760
    [Abstract] [Full Text] [Related]

  • 4. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
    Stigbrand T, Riklund K, Tholander B, Hirano K, Lalos O, Stendahl U.
    Eur J Gynaecol Oncol; 1990 Oct; 11(5):351-60. PubMed ID: 2097151
    [Abstract] [Full Text] [Related]

  • 5. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
    Rasmuson T, Björk GR, Damber L, Jacobsson L, Jeppsson A, Stigbrand T, Westman G.
    Acta Oncol; 1987 Oct; 26(4):261-7. PubMed ID: 3479987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.
    Harmenberg U, Frödin JE, Ljungdahl-Stähle E, Mellstedt H, Wahren B, Stigbrand T.
    Tumour Biol; 1989 Oct; 10(5):225-31. PubMed ID: 2814231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA, Marín J, Jover JM, Fernández R, Fradejas J, Moreno M.
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H, Sekiya S, Takamizawa H, Suzuki N, Tokita H.
    Arch Gynecol Obstet; 1988 May; 243(2):69-81. PubMed ID: 3165255
    [Abstract] [Full Text] [Related]

  • 19. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A, Yakushiji M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):47-54. PubMed ID: 2157782
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.